128 related articles for article (PubMed ID: 2853876)
1. Synaptosomal dopamine autoreceptors: sensitivity changes after in vitro and in vivo treatments.
Tissari AH
Pharmacol Res Commun; 1988 Nov; 20(11):1001-11. PubMed ID: 2853876
[TBL] [Abstract][Full Text] [Related]
2. Reduction of dopamine synthesis inhibition by dopamine autoreceptor activation in striatal synaptosomes with in vivo reserpine administration.
Tissari AH; Lillgäls MS
J Neurochem; 1993 Jul; 61(1):231-8. PubMed ID: 8099951
[TBL] [Abstract][Full Text] [Related]
3. Presynaptic dopamine autoreceptors control tyrosine hydroxylase activation in depolarized striatal dopaminergic terminals.
el Mestikawy S; Glowinski J; Hamon M
J Neurochem; 1986 Jan; 46(1):12-22. PubMed ID: 2866232
[TBL] [Abstract][Full Text] [Related]
4. Evidence that adenosine A2 and dopamine autoreceptors antagonistically regulate tyrosine hydroxylase activity in rat striatal synaptosomes.
Onali P; Olianas MC; Bunse B
Brain Res; 1988 Jul; 456(2):302-9. PubMed ID: 2905190
[TBL] [Abstract][Full Text] [Related]
5. Reduced sensitivity of synaptosomal dopamine autoreceptors following increase in synaptosomal dopamine synthesis.
Tissari AH
Eur J Pharmacol; 1985 Mar; 109(3):433-4. PubMed ID: 3987811
[No Abstract] [Full Text] [Related]
6. Effects of in vivo amphetamine administration on dopamine synthesis regulation in rat brain striatal synaptosomes.
Patrick RL; Berkowitz AL; Regenstein AC
J Pharmacol Exp Ther; 1981 Jun; 217(3):686-91. PubMed ID: 7229999
[TBL] [Abstract][Full Text] [Related]
7. Dopamine autoreceptor regulation of the kinetic state of striatal tyrosine hydroxylase.
Strait KA; Kuczenski R
Mol Pharmacol; 1986 Jun; 29(6):561-9. PubMed ID: 2872588
[TBL] [Abstract][Full Text] [Related]
8. Apomorphine enantiomers' effects on dopamine metabolism: receptor and non-receptor related actions.
Saller CF; Salama AI
Eur J Pharmacol; 1986 Feb; 121(2):181-8. PubMed ID: 3699091
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of reserpine and tetrabenazine on rat striatal synaptosomal dopamine biosynthesis and synaptosomal dopamine pools.
Kuczenski R
J Pharmacol Exp Ther; 1977 May; 201(2):357-67. PubMed ID: 870679
[TBL] [Abstract][Full Text] [Related]
10. Dopamine synthesis in synaptosomes: relation of autoreceptor functioning to pH, membrane depolarization, and intrasynaptosomal dopamine content.
Saller CF; Salama AI
J Neurochem; 1984 Sep; 43(3):675-88. PubMed ID: 6747629
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of D- and L-amphetamine and methylphenidate on rat striatal dopamine biosynthesis.
Kuczenski R; Segal DS
Eur J Pharmacol; 1975 Feb; 30(2):244-51. PubMed ID: 1126362
[TBL] [Abstract][Full Text] [Related]
12. Evidence that amphetamine and Na+ gradient reversal increase striatal synaptosomal dopamine synthesis through carrier-mediated efflux of dopamine.
Connor CE; Kuczenski R
Biochem Pharmacol; 1986 Sep; 35(18):3123-30. PubMed ID: 3092833
[TBL] [Abstract][Full Text] [Related]
13. [3H]Dopamine release by d-amphetamine from striatal synaptosomes of reserpinized rats.
Masuoka DT; Alcaraz AF; Schott HF
Biochem Pharmacol; 1982 Jun; 31(11):1969-74. PubMed ID: 7115417
[TBL] [Abstract][Full Text] [Related]
14. Relative selectivity of 6,7-dihydroxy-2-dimethylaminotetralin, N-n-propyl-3-(3-hydroxyphenyl)piperidine, N-n-propylnorapomorphine and pergolide as agonists at striatal dopamine autoreceptors and postsynaptic dopamine receptors.
Claustre Y; Fage D; Zivkovic B; Scatton B
J Pharmacol Exp Ther; 1985 Feb; 232(2):519-25. PubMed ID: 2857197
[TBL] [Abstract][Full Text] [Related]
15. Increase of dopamine synthesis in synaptosomes from rats treated with neuroleptics or reserpine.
Tissari AH
Med Biol; 1982 Feb; 60(1):38-41. PubMed ID: 6121960
[TBL] [Abstract][Full Text] [Related]
16. Presynaptic inhibition of dopamine synthesis in rat striatal tissue by enantiomeric mono- and dihydroxyaporphines.
Booth RG; Baldessarini RJ; Kula NS; Gao Y; Zong R; Neumeyer JL
Mol Pharmacol; 1990 Jul; 38(1):92-101. PubMed ID: 1973525
[TBL] [Abstract][Full Text] [Related]
17. The effect of apomorphine and bradykinin on uptake and release of dopamine in vitro by striatal synaptosomes of the rat.
Borawska M; Wiśniewski K
Pol J Pharmacol Pharm; 1982; 34(1-3):79-84. PubMed ID: 7167424
[TBL] [Abstract][Full Text] [Related]
18. Is inhibition of striatal synaptosomal tyrosine hydroxylation by dopamine agonists a measure of dopamine autoreceptor function?
Fowler CJ; Thorell G; Andersson M; Magnusson O
Naunyn Schmiedebergs Arch Pharmacol; 1985 Oct; 331(1):12-9. PubMed ID: 2866447
[TBL] [Abstract][Full Text] [Related]
19. Interactions between endogenous dopamine and dopamine agonists at release modulatory receptors: multiple effects of neuronal uptake inhibitors on transmitter release.
Hoffmann IS; Talmaciu RK; Cubeddu LX
J Pharmacol Exp Ther; 1986 Aug; 238(2):437-46. PubMed ID: 2942676
[TBL] [Abstract][Full Text] [Related]
20. Presynaptic inhibition of dopamine synthesis in rat striatum: effects of chronic dopamine depletion and receptor blockade.
Reches A; Wagner HR; Jackson-Lewis V; Fahn S
Brain Res; 1985 Nov; 347(2):346-9. PubMed ID: 3933764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
